Belpointe Asset Management
NMTC icon

Belpointe Asset Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Belpointe Asset Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.9K Hold
12,500
– – ﹤0.01% 1146
2026
Q2 		$38K Hold
12,500
– – ﹤0.01% 1115
2026
Q1 		$58.2K Buy
+12,500
New +$60K ﹤0.01% 1054
2023
Q1 		– Sell
-114
Closed -$818 – 3811
2022
Q4 		$818 Buy
+114
New +$1.02K ﹤0.01% 3474

Other funds holding NMTC

Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Princeton Global Asset Management
Princeton Global Asset Management Princeton, New Jersey $692M AUM 20.31% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Belpointe Asset Management's NMTC Position: Q3 2026 in Review

Belpointe Asset Management held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 12,500 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Belpointe Asset Management first reported a position in NMTC in Q4 2022 and has held it in 4 quarters since. The position peaked at $58.2K in Q1 2026. 13 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • Belpointe Asset Management held 12,500 shares of NeuroOne Medical Technologies worth $12.9K as of Q3 2026.
  • Belpointe Asset Management left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Belpointe Asset Management's portfolio in Q3 2026, its #1146 holding.
  • Belpointe Asset Management first reported a position in NeuroOne Medical Technologies in Q4 2022 and has held it in 4 quarters since.
  • Belpointe Asset Management's NeuroOne Medical Technologies position peaked at $58.2K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on Belpointe Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.